MyMD Pharmaceuticals increases authorized Series G Preferred shares from 8,950 to 12,826,273 for in-kind dividends

Q/C TECHNOLOGIES, INC.

On June 17, 2024, MyMD filed a Certificate of Amendment to increase authorized Series G Convertible Preferred Stock from 8,950 to 12,826,273 shares.
The amendment enables payment of dividends 'in kind' in the form of additional Preferred Stock shares, per Section 3 of the Certificate of Designations.
The amendment was approved by Required Holders and became effective upon filing with the Delaware Secretary of State.
The Company had previously entered into a Securities Purchase Agreement on May 20, 2024 for sale of Preferred Stock and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.